Works matching AU Perfetti, Riccardo


Results: 38
    1
    2

    Propensity‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2821, doi. 10.1111/dom.13462
    By:
    • Rosenstock, Julio;
    • Handelsman, Yehuda;
    • Vidal, Josep;
    • Ampudia Blasco, F. Javier;
    • Giorgino, Francesco;
    • Liu, Minzhi;
    • Perfetti, Riccardo;
    • Meier, Juris J.
    Publication type:
    Article
    3

    Rational drug design and PPAR Agonists.

    Published in:
    Current Diabetes Reports, 2005, v. 5, n. 5, p. 340, doi. 10.1007/s11892-005-0091-3
    By:
    • Perfetti, Riccardo;
    • D’Amico, Eugenio
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.

    Published in:
    Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02135-z
    By:
    • Januzzi, James L.;
    • Del Prato, Stefano;
    • Rosenstock, Julio;
    • Butler, Javed;
    • Ezekowitz, Justin;
    • Ibrahim, Nasrien E.;
    • Lam, Carolyn S.P.;
    • Marwick, Thomas;
    • Wilson Tang, W. H.;
    • Liu, Yuxi;
    • Mohebi, Reza;
    • Urbinati, Alessia;
    • Zannad, Faiez;
    • Perfetti, Riccardo
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Results of the ACTION‐Galactosemia Kids Study to Evaluate the Effects of Govorestat in Pediatric Patients with Classic Galactosemia.

    Published in:
    Journal of Clinical Pharmacology, 2025, v. 65, n. 5, p. 575, doi. 10.1002/jcph.6170
    By:
    • Bailey, Evan;
    • Phan, Han;
    • Ahmad, Ayesha;
    • Thomas, Janet;
    • Ames, Elizabeth G.;
    • Pritchard, Amanda B.;
    • Quinonez, Shane C.;
    • Wang, Stella;
    • Dayley, Caleb;
    • Salt, Andrew;
    • Pick, Christina;
    • Durrant, Abe;
    • Johnson, Samuel;
    • Nicodemus‐Johnson, Jessie;
    • Dickson, Samuel P.;
    • Perfetti, Riccardo;
    • Hendrix, Suzanne B.;
    • Shendelman, Shoshana
    Publication type:
    Article
    27
    28
    29

    Population Pharmacokinetic/Pharmacodynamic Model of Subcutaneous Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Activity After Oral Administration of AMG 221, a Selective 11β-HSD1 Inhibitor.

    Published in:
    Journal of Clinical Pharmacology, 2011, v. 51, n. 6, p. 830, doi. 10.1177/0091270010374470
    By:
    • Gibbs, John P.;
    • Emery, Maurice G.;
    • McCaffery, Ian;
    • Smith, Brian;
    • Gibbs, Megan A.;
    • Akrami, Anna;
    • Rossi, John;
    • Paweletz, Katherine;
    • Gastonguay, Marc R.;
    • Bautista, Edgar;
    • Wang, Minghan;
    • Perfetti, Riccardo;
    • Daniels, Oranee
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36

    3,5,3'-Triiodo-L-thyronine enhances the differentiation of a human pancreatic duct cell line (hPANC-1) towards a -cell-Like phenotypeSilvia Misiti and Emanuela Anastasi contributed equally to this work.

    Published in:
    Journal of Cellular Physiology, 2005, v. 204, n. 1, p. 286, doi. 10.1002/jcp.20293
    By:
    • Silvia Misiti;
    • Emanuela Anastasi;
    • Salvatore Sciacchitano;
    • Cecilia Verga Falzacappa;
    • Laura Panacchia;
    • Barbara Bucci;
    • Daniele Khouri;
    • Ilaria D'Acquarica;
    • Ercole Brunetti;
    • Umberto Di Mario;
    • Vincenzo Toscano;
    • Riccardo Perfetti
    Publication type:
    Article
    37
    38